Inflammatory cell dynamics after murine femoral artery wire injury: A multi-parameter flow cytometry-based analysis.

Pamulapati V, Cuda CM, Smith TL, Jung J, Xiong L, Swaminathan S, and Ho KJ. Cells. 2023. Accepted February 17, 2023.

 

Plasma Gut Microbe-Derived Metabolites Associated with Peripheral Artery Disease and Major Adverse Cardiac Events.

Ho KJ, Ramirez JL, Kulkarni R, Harris KG, Helenowski I, Xiong L, Ozaki CK, and Grenon SM. Microorganisms. 2022;10:2065. https://doi.org/10.3390/microorganisms10102065

 

Identifying gaps in disease knowledge among patients with peripheral artery disease.

Byskosh N, Pamulapati V, Xu S, Vavra AK, Hoel AW, Tian L, McDermott MM, Butt Z, Ho KJ. Journal of Vascular Surgery. 2021 Nov 15;S0741-5214(21)02441-1.

 

Use of computed tomographic and digital subtraction angiography to determine optimal duplex ultrasound criteria for predicting superior mesenteric artery in-stent restenosis.

Pampulapati V,* Guitart JR,* Helenowski IB, Resnick S, Ho KJ. Vasc Med. 2021 Oct;26(5):566-568. 

*Equal contribution

 

Limb ischemia and bleeding in patients requiring veno-arterial extracorporeal membrane oxygenation.

Son A,* Ngo Khanh L,* Joung H, Guerra A, Karim A, McGregor R, Pawale A, Pham D, Ho KJ. Journal of Vascular Surgery. 2021 Feb;73(2):593-600.

*Equal contribution

 

The comorbidity-polypharmacy score is an objective and practical predictor of outcomes and mortality after vascular surgery.

Ngo Khanh L, Helenowski I, Zamor K, Scott M, Hoel AW, Ho KJ. Annals of Vascular Surgery. 2020 Nov;69:206-216.

 

Microbe-derived butyrate and its receptor free fatty acid receptor 3 (FFAR3) but not FFAR2 mitigate neointimal hyperplasia susceptibility after arterial injury.

Nooromid, M,* Chen EC,* Xiong L,  Shapiro K, Jiang Q, Demsas F, Eskandari M, Priyadarshini M, Chen EC, Layden BT, Ho KJ. J Am Heart Assoc. 2020 Jul 7;9(13):e016235.

*Equal contribution

 

Predictors and consequences of loss to follow-up after vascular surgery.

Ngo Khanh L, Helenowski I, Zamor K, Scott M, Hoel AW, Ho KJ. Annals of Vascular Surgery. 2020 Oct;68:217-225.

 

Targeted inhibition of gut microbial TMAO production reduces renal tubulointerstitial fibrosis and functonal impairment in a murine model of chronic kidney disease.

Microbial colonization of germ-free mice restores neointimal hyperplasia development after arterial injury.

Chen EB, Shapiro KE, Wun K, Kuntz T, Theriault BR, Nooromid MJ, Leone VA, Harris KG, Jiang Q, Spedale M, Xiong L, Gilbert JA, Chang EB, Ho KJ. J Am Heart Assoc. 2020 Mar 3;9(5):e013496.

 

Microbiota composition modulates inflammation and neointimal hyperplasia after arterial angioplasty.

Cason CA, Kuntz TM, Chen EB, Wun K, Noormid MJ, Xiong L, Gottel NR, Harris KG, Morton TC, Avram MJ, Chang EB, Gilbert JA, Ho, KJ. J Vasc Surg. 2020 Apr;71(4):1378-1389.e3.

 

Microbiota control acute arterial inflammation and neointimal hyperplasia development after arterial injury.

 

Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes.

Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions.

Comparison of Direct and Less Invasive Techniques for the Treatment of Severe Aorto-Iliac Occlusive Disease.

Zamor KC, Hoel AW, Helenowski IB, Beck AW, Schneider JR, Ho KJ.

Ann Vasc Surg. 2018 Jan;46:226-233. doi: 10.1016/j.avsg.2017.07.002. Epub 2017 Jul 21.

PMID: 28739459